Propeller Health announced recently that is has earned HITRUST CSF certified status, meaning that its asthma and COPD management system meets key healthcare regulations and requirements for protecting and securing sensitive private…
Propeller Health announced recently that its digital solution for asthma and COPD will be available to members of Express Scripts, a company that provides integrated pharmacy benefit management services. “With…
Propeller Health is one of five health startups to join together to form a new industry association, the Digital Therapeutics Alliance (DTA), which announced its launch at the Connected Health…
Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently. “We are excited to be working closely with GSK…
Propeller Health announced today it has partnered with Novartis Pharma AG to develop a custom add-on sensor for the Breezhaler inhaler to further improve adherence and care management for people living with COPD…
Propeller Health announced today that it will collaborate with Medical International Research (MIR), a global leader in spirometry, oximetry and telemedicine, to integrate several of MIR’s mobile and clinical spirometers into the…
Propeller Health received clearance from the U.S. Food and Drug Administration on its Propeller platform for use with GlaxoSmithKline’s Ellipta inhaler, the company announced today. “Today, we are pleased to announce…
Propeller Health announced today that it completed a $21.5 million Series C financing round. According to a release, the funds will be used to expand the company’s digitally guided therapy…
To improve adherence and care management for people living with COPD and asthma, Propeller Health today announced it will partner with global pharmaceutical company Boehringer Ingelheim. “We are excited to…
Propeller Health announced this week that it was cleared by the FDA to market its platform with medications using GlaxoSmithKline’s Diskus dry powder inhaler. “Today we’re excited to announce back-to-back…
